BREAKING
Why Is PLTR Stock Up Today? Technical Rebound Follows Brutal February Selloff 13 hours ago Palantir Technologies Inc. (PLTR) Surges 5.0% — Developing Story 13 hours ago Live Nation Entertainment, inc (LYV) Misses Q4 2025 Earnings Estimates — EPS $0.73 vs $1.49 Expected 13 hours ago GRAIL, Inc (GRAL) Tops Q4 2025 Earnings Estimates — EPS $-2.46 vs $-3.26 Expected 13 hours ago Sensata (ST) Beats Q4 EPS Estimates By 4.6% In Third Consecutive Quarter 13 hours ago Sensata Technologies Holding plc (ST) Tops Q4 2025 Earnings Estimates — EPS $0.89 vs $0.85 Expected 13 hours ago Vicor (VICR) Q4 EPS of $0.63 Crushes Estimates by 425%, Revenue Surges 27.8% 13 hours ago Vicor Corporation (VICR) Tops Q4 2025 Earnings Estimates — EPS $0.63 vs $0.12 Expected 13 hours ago Why RingCentral Stock Dropped Despite Beating Earnings Estimates by 5.2% 13 hours ago RingCentral, Inc (RNG) Tops Q4 2025 Earnings Estimates — EPS $1.13 vs $1.07 Expected 13 hours ago Why Is PLTR Stock Up Today? Technical Rebound Follows Brutal February Selloff 13 hours ago Palantir Technologies Inc. (PLTR) Surges 5.0% — Developing Story 13 hours ago Live Nation Entertainment, inc (LYV) Misses Q4 2025 Earnings Estimates — EPS $0.73 vs $1.49 Expected 13 hours ago GRAIL, Inc (GRAL) Tops Q4 2025 Earnings Estimates — EPS $-2.46 vs $-3.26 Expected 13 hours ago Sensata (ST) Beats Q4 EPS Estimates By 4.6% In Third Consecutive Quarter 13 hours ago Sensata Technologies Holding plc (ST) Tops Q4 2025 Earnings Estimates — EPS $0.89 vs $0.85 Expected 13 hours ago Vicor (VICR) Q4 EPS of $0.63 Crushes Estimates by 425%, Revenue Surges 27.8% 13 hours ago Vicor Corporation (VICR) Tops Q4 2025 Earnings Estimates — EPS $0.63 vs $0.12 Expected 13 hours ago Why RingCentral Stock Dropped Despite Beating Earnings Estimates by 5.2% 13 hours ago RingCentral, Inc (RNG) Tops Q4 2025 Earnings Estimates — EPS $1.13 vs $1.07 Expected 13 hours ago
CYTK

Cytokinetics, Incorporated

$CYTK NASDAQ Aug 5, 2021 AMC Q2 2021

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

CYTK Coverage

Event Cytokinetics, Incorporated (CYTK) Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy Feb 17, 2026 Event Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Call Feb 13, 2026 Event Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Announcement Feb 13, 2026 Transcript Cytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript Jan 22, 2026